Emerging data showed that inhibiting ileal FXR-FGF15 induced beneficial effects alleviating non-alcoholic fatty liver disease (NAFLD), obesity, and insulin resistance (53, 54). The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.